Clinical Research Units Hungary
5
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
Role: collaborator
A Study to Assess the Phamacokinetics of BV100 in Participants with Varying Degrees of Hepatic Impairment
Role: collaborator
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100
Role: collaborator
A Study to Assess Effect of BV100 on the Pharmacokinetics of Midazolam in Healthy Participants
Role: collaborator
Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment
Role: collaborator
All 5 trials loaded